In a preclinical model of colorectal cancer, the addition Bacteroides spp into a bacterial consortium increased the frequency of IFN-γ+CD8+ tumor-infiltrating lymphocytes, which positively influenced the efficacy of anti-PD-1.123. The gene discussed is CD8A; the disease is neoplasm.